9 Meters Biopharma (NMTRQ)
OTHER OTC:NMTRQ
US Market
Holding NMTRQ?
Track your performance easily

9 Meters Biopharma (NMTRQ) Financial Statements

1,981 Followers

9 Meters Biopharma Financial Overview

9 Meters Biopharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; 9 Meters Biopharma is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit--$ 0.00--
EBIT$ -13.12M$ -10.95M$ -8.51M$ -11.13M$ -11.35M
EBITDA$ -12.54M$ -9.61M$ -8.51M$ -11.13M$ -11.35M
Net Income Common Stockholders$ -13.87M$ -11.93M$ -9.35M$ -11.13M$ -11.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.58M$ 29.61M$ 15.86M$ 29.46M$ 37.24M
Total Assets$ 9.26M$ 33.15M$ 42.14M$ 31.51M$ 39.26M
Total Debt$ 5.17M$ 19.73M$ 18.52M$ 141.36K$ 154.85K
Net Debt$ -2.42M$ -9.88M$ 2.66M$ -29.31M$ -37.09M
Total Liabilities$ 15.61M$ 30.75M$ 28.67M$ 9.42M$ 8.32M
Stockholders Equity$ -6.30M$ 2.40M$ 13.46M$ 22.09M$ 30.94M
Cash Flow-
Free Cash Flow$ 17.01M$ -9.74M$ -9.97M$ -7.79M$ -9.75M
Operating Cash Flow$ 17.01M$ -9.74M$ -9.97M$ -7.79M$ -9.75M
Investing Cash Flow--$ 0.00$ 0.00$ -2.84K
Financing Cash Flow$ -12.29M-$ 19.91M$ 0.00$ 0.00
Currency in USD

9 Meters Biopharma Earnings and Revenue History

9 Meters Biopharma Debt to Assets

9 Meters Biopharma Cash Flow

9 Meters Biopharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis